AKIN GUMP STRAUSS HAUER & FELD for SHATTERPROOF
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Implementation of funding provided for in Consolidated Appropriations Act, 2021 (P.L. 116-260) to address substance use disorder; Mainstreaming Addiction Treatment Act (H.R. 1384/S. 445); Medication Access and Training Expansion Act (H.R. 2067/S. 2235); Fiscal Year 2022 appropriations report language regarding substance use disorder treatment; Medicaid Reentry Act of 2021 (H.R. 955/S. 285); Collaborate in an Orderly and Cohesive Manner Act (H.R.5218); Comprehensive Addiction Resources Emergency Act of 2021 (H.R. 6311/S. 3418); Synthetic Opioid Danger Awareness Act (H.R. 2364); FENTANYL Results Act (H.R. 2538/S. 1160).
| Lobbyist | Covered position, as disclosed |
|---|---|
| LOUIS AGNELLO | — |
| CASEY CHRISTINE HIGGINS New | Asst to Spkr for Policy and Trade Cnsl, Paul Ryan, Nov 15-Jan 19; Trade Cncl to House Ways & Means, Jan 15-Nov 15; LC to Rep. Paul Ryan, Oct 11-Jan 15; Law Clrk House Budget Comm, Sep 09-May 10. |
| JULIE NOLAN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.